Thomas will present the findings at the following oral presentation session: Oral Presentations - Weighing Opportunities of Incretin-Based Therapy in Obesity Retatrutide, an Agonist of GIP, GLP-1, and Glucagon Receptors, Improves Markers of Pancreatic Beta-Cell Function and Insulin Sensitivity Presented on Sunday, June 23, 2024 at 2:45 PM EDT ### About the ADAs Scientific Sessions The ADA's 84th Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be held in Orlando, FL on June 21-24
Protein shakes can be appealing when appetite is low, offering a way to hit protein targets without navigating the mechanics of a solid meal
doi: 10.2337/db17-0480 23 KoffertJHonkaHTeuhoJKauhanenSHurmeSParkkolaRet al
Patients using injectable therapies should use an appropriate sharps disposal container and follow local disposal rules